How to buy Gain Therapeutics stock
Learn how to easily invest in Gain Therapeutics stock.
Gain Therapeutics is a biotechnology business based in the US. Gain Therapeutics shares (GANX) are listed on the NASDAQ and all prices are listed in US Dollars. Gain Therapeutics employs 28 staff and has a trailing 12-month revenue of around $55,180.
How to buy Gain Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GANX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Gain Therapeutics stock price (NASDAQ: GANX)Use our graph to track the performance of GANX stocks over time.
Gain Therapeutics shares at a glance
|Latest market close||$3.20|
|52-week range||$2.80 - $6.19|
|50-day moving average||$4.01|
|200-day moving average||$4.14|
|Wall St. target price||$9.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.75|
Buy Gain Therapeutics stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Gain Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Gain Therapeutics price performance over time
|1 week (2023-09-20)||-5.88%|
|1 month (2023-08-28)||-7.25%|
|3 months (2023-06-28)||-28.73%|
|6 months (2023-03-28)||-31.62%|
|1 year (2022-09-28)||-4.48%|
|2 years (2021-09-28)||-58.71%|
|3 years (2020-09-24)||N/A|
|5 years (2018-09-24)||N/A|
Gain Therapeutics financials
|Gross profit TTM||$-7,660,886|
|Return on assets TTM||-55.52%|
|Return on equity TTM||-115.76%|
|Market Capitalization||$42.5 million|
TTM: trailing 12 months
Gain Therapeutics share dividends
We're not expecting Gain Therapeutics to pay a dividend over the next 12 months.
Gain Therapeutics share price volatility
Over the last 12 months, Gain Therapeutics's shares have ranged in value from as little as $2.8 up to $6.19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Gain Therapeutics's is 0.3262. This would suggest that Gain Therapeutics's shares are less volatile than average (for this exchange).
To put Gain Therapeutics's beta into context you can compare it against those of similar companies.
Gain Therapeutics overview
Gain Therapeutics, Inc. , a biotechnology company, researches and develops novel therapies to treat diseases caused by protein misfolding in Switzerland and Spain. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. Its lead product candidate includes GT-02287, for the treatment of GBA1 Parkinson's disease. In addition, the company is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. Gain Therapeutics, Inc.
Gain Therapeutics in the news
Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023
Gain Therapeutics to Present at the Cambridge Healthtech Institute’s 2nd Annual Neurodegeneration Targets Conference
Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia
Frequently asked questionsWhat percentage of Gain Therapeutics is owned by insiders or institutions?
Currently 20.823% of Gain Therapeutics shares are held by insiders and 10.41% by institutions. How many people work for Gain Therapeutics?
Latest data suggests 28 work at Gain Therapeutics. When does the fiscal year end for Gain Therapeutics?
Gain Therapeutics's fiscal year ends in December. Where is Gain Therapeutics based?
Gain Therapeutics's address is: 4800 Montgomery Lane, Bethesda, MD, United States, 20814 What is Gain Therapeutics's ISIN number?
Gain Therapeutics's international securities identification number is: US36269B1052
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert